ARTICLE | Product Development
Pfizer, J&J, Merck and Moderna to testify on COVID-19 vaccine status
July 21, 2020 1:36 AM UTC
In testimony prepared for a congressional hearing Tuesday, Pfizer reiterated its goal of submitting a request to FDA for emergency use of a COVID-19 vaccine candidate “as early as October,” and AstraZeneca expressed hope that Phase III data from its candidate will be ready in the fall.
Johnson & Johnson (NYSE:JNJ), Merck & Co. Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), which will also testify Tuesday at a House Energy & Commerce Committee hearing, were not as specific about the timelines for their COVID-19 vaccine candidates. ...